Company intelligence / Profile preview
Shanghai YaKe Biotechnology
Shanghai, Shanghai, Chinanature.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Shanghai YaKe Biotechnology is a leading Chinese biotech focused on developing next-generation autologous and universal CAR-T therapies for hematological malignancies. Its lead assets target well-established antigens such as CD19 and BCMA for leukemias and myeloma. The company has several candidates in Phase II trials with promising activity against relapsed/refractory blood cancers. Early-stage programs include novel targets like GPRC5D and multi-antigen approaches. Clinical results are not yet published but the breadth of the pipeline suggests robust R&D.
- Therapeutic areas
- OncologyRare DiseasesImmunologyHematologyRheumatology
- Modalities
- CAR-T cell therapyAutologous CAR-T cell therapyUniversal CAR-T cell therapyHematopoietic stem cell therapyGene therapy
- Industry
- Biotech
02
Drug pipeline
23 assets22 more assets in the full pipeline.
Request access →03
Partnerships
Zhejiang University is a collaborator on at least two early-phase clinical trials of anti-CD5-CAR T cells. No major pharma partnerships disclosed.
Beyond the preview
Go deeper on Shanghai YaKe Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai YaKe Biotechnology.